Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

4.15
Delayed Data
As of Jul 26
 +0.25 / +6.41%
Today’s Change
2.12
Today|||52-Week Range
5.29
+25.76%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close3.90
Today’s open3.37
Day’s range3.37 - 4.15
Volume10,084
Average volume (3 months)17,583
Market cap$59.7M
Dividend yield--
Data as of 07/26/2017

Growth & Valuation

Earnings growth (last year)+79.47%
Earnings growth (this year)+62.14%
Earnings growth (next 5 years)--
Revenue growth (last year)+171.56%
P/E ratioNM
Price/Sales2.61
Price/Book8.39

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...-0.03-0.83%
XENEXenon Pharmaceutical...+0.05+1.52%
RGLSRegulus Therapeutics...+0.08+7.21%
ATXIAvenue Therapeutics ...+0.03+0.43%
Data as of 07/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$11.9M
Annual profit (last year)-$13.2M
Net profit margin-110.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer
Jack J. McGovern
Corporate headquarters
Emeryville, California

Forecasts